Literature DB >> 9243560

Comparison of self-reported drug use with quantitative and qualitative urinalysis for assessment of drug use in treatment studies.

K L Preston1, K Silverman, C R Schuster, E J Cone.   

Abstract

The effectiveness of substance abuse treatment programs can be monitored by self-reported drug use and objectively measured by qualitative and quantitative urinalysis. The advantages and disadvantages of each of these three methods of assessing drug use are reviewed. Data collected in a clinical trial of a behavioral treatment for cocaine abuse are used to evaluate the relationships among qualitative and quantitative urinalysis for cocaine metabolite and self-reported cocaine use. Qualitative and quantitative urine testing showed greater rates of drug use than that shown by self-report, though there were significant correlations between self-reported use and urine toxicology results. Benzoylecgonine concentrations in urine specimens supported the suggestions that rates of drug use as determined by qualitative urinalysis are artificially high due to carryover and were informative about subjects' patterns of use.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9243560

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN: 1046-9516


  9 in total

1.  Combining psychometric and biometric measures of substance use.

Authors:  Richard Lennox; Michael L Dennis; Christy K Scott; Rod Funk
Journal:  Drug Alcohol Depend       Date:  2005-12-20       Impact factor: 4.492

2.  HealthCall: technology-based extension of motivational interviewing to reduce non-injection drug use in HIV primary care patients - a pilot study.

Authors:  Efrat Aharonovich; Eliana Greenstein; Ann O'Leary; Barbara Johnston; Simone G Seol; Deborah S Hasin
Journal:  AIDS Care       Date:  2012-03-20

3.  Comparison Between Urinalysis Results and Self-Reported Heroin Use Among Patients Undergoing Methadone Maintenance Treatment in China.

Authors:  Li Li; Li-Jung Liang; Chunqing Lin; Nan Feng; Zunyou Wu
Journal:  Subst Use Misuse       Date:  2017-03-27       Impact factor: 2.164

4.  Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone.

Authors:  David A Fiellin; Linda Weiss; Michael Botsko; James E Egan; Frederick L Altice; Lauri B Bazerman; Amina Chaudhry; Chinazo O Cunningham; Marc N Gourevitch; Paula J Lum; Lynn E Sullivan; Richard S Schottenfeld; Patrick G O'Connor
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

5.  Use of alcohol and drugs by Norwegian employees: a pilot study using questionnaires and analysis of oral fluid.

Authors:  Hallvard Gjerde; Asbjørg S Christophersen; Inger S Moan; Borghild Yttredal; J Michael Walsh; Per T Normann; Jørg Mørland
Journal:  J Occup Med Toxicol       Date:  2010-06-15       Impact factor: 2.646

6.  Patients in treatment centres: are they all dependents?

Authors:  R Jain; A Dhawan; R Kumar; R Ray; R Singh
Journal:  Indian J Psychiatry       Date:  2001-10       Impact factor: 1.759

7.  Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.

Authors:  Stacey C Sigmon; Andrew C Meyer; Bryce Hruska; Taylor Ochalek; Gail Rose; Gary J Badger; John R Brooklyn; Sarah H Heil; Stephen T Higgins; Brent A Moore; Robert P Schwartz
Journal:  Addict Behav       Date:  2015-07-29       Impact factor: 3.913

Review 8.  Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.

Authors:  Paul W Czoty; William W Stoops; Craig R Rush
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

9.  Psychosocial functioning and cocaine use during treatment: strength of relationship depends on type of urine-testing method.

Authors:  Udi E Ghitza; David H Epstein; Kenzie L Preston
Journal:  Drug Alcohol Depend       Date:  2007-07-10       Impact factor: 4.492

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.